EssilorLuxottica SA (USD) EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, Europe, Latin America, Asia, Oceania, and Africa. It operates in five segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale segment engages in the manufacture and wholesale distribution of luxury and sports eyewear. The Retail segment retails luxury and sports eyewear. The Lenses and Optical Instruments segment offers lenses and small equipment, including Varilux progressive lenses; Crizal antireflective, anti-smudge, and antistatic lenses; Transitions photochromic lenses; Eyezen lenses for users of computers, tablets, smartphones, and other connected devices; Xperio polarized sun lenses; and Nikon and Kodak corrective lens brands. It also provides lens edging and mounting instruments for opticians and prescription laboratories; optometry instruments for eye care professionals, schools, occupational medicine centers, military, and other institutions; and Transitions Signature Gen 8 photochromic lens, as well as develops solutions for online sales of optical products. The Equipment segment offers digital surfacing machines and lens coating machines to prescription laboratories, integrated optical chains, and lens manufacturers. The Sunglasses and Readers segment provides non-prescription sunglasses and reading glasses under the Foster Grant, Gargoyles, Magnivision, Corinne McCormack, Monkey Monkey, Ryders Eyewear, and SolarShield brands; Reebok, Steve Madden, Betsey Johnson, Nine West, Dockers, French Connection, Ironman, Rawlings, Bodyglove, Panama Jack, Marvel, and Disney; Bolon, Molsion, Qina, and Prosun brands; and Mujosh and Aojo brands. It has a network of 490 prescription laboratories and edging-mounting facilities. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

EssilorLuxottica SA (USD) Active

1-5 rue Paul CEzanne, Paris, FR, 75008

Stock Price USD

Price Change

Last Dividend USD

C-

Latest Rating

ESLOY's stock peer is BDX (Becton, Dickinson and Company)

ESLOY's stock peer is CLPBF (Coloplast A/S)

ESLOY's stock peer is CLPBY (Coloplast A/S)

ESLOY's stock peer is CZMWF (Carl Zeiss Meditec AG)

ESLOY's stock peer is CZMWY (Carl Zeiss Meditec AG)

ESLOY's stock peer is ESLOF (EssilorLuxottica SA)

ESLOY's stock peer is HOCPY (HOYA Corporation)

ESLOY's stock peer is SAUHY (Straumann Holding AG)

ESLOY's stock peer is SSMXY (Sysmex Corporation)

Healthcare Medical - Instruments & Supplies

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, Europe, Latin America, Asia, Oceania, and Africa. It operates in five segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale segment engages in the manufacture and wholesale distribution of luxury and sports eyewear. The Retail segment retails luxury and sports eyewear. The Lenses and Optical Instruments segment offers lenses and small equipment, including Varilux progressive lenses; Crizal antireflective, anti-smudge, and antistatic lenses; Transitions photochromic lenses; Eyezen lenses for users of computers, tablets, smartphones, and other connected devices; Xperio polarized sun lenses; and Nikon and Kodak corrective lens brands. It also provides lens edging and mounting instruments for opticians and prescription laboratories; optometry instruments for eye care professionals, schools, occupational medicine centers, military, and other institutions; and Transitions Signature Gen 8 photochromic lens, as well as develops solutions for online sales of optical products. The Equipment segment offers digital surfacing machines and lens coating machines to prescription laboratories, integrated optical chains, and lens manufacturers. The Sunglasses and Readers segment provides non-prescription sunglasses and reading glasses under the Foster Grant, Gargoyles, Magnivision, Corinne McCormack, Monkey Monkey, Ryders Eyewear, and SolarShield brands; Reebok, Steve Madden, Betsey Johnson, Nine West, Dockers, French Connection, Ironman, Rawlings, Bodyglove, Panama Jack, Marvel, and Disney; Bolon, Molsion, Qina, and Prosun brands; and Mujosh and Aojo brands. It has a network of 490 prescription laboratories and edging-mounting facilities. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

60%

Dcf Rating

20%

Return On Equity

20%

Return On Assets

40%

Debt To Equity

20%

Price To Earnings

20%

Price To Book

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
2025-05-12	2025-06-26	2.25	1.62 %	Annual
2024-05-06	2024-06-18	2.11	1.97 %	Annual
2023-05-23	2023-06-28	1.77	1.82 %	Annual
2022-05-31	2022-07-06	1.32	1.64 %	Annual
2021-06-07	2021-07-06	0.66	0.75 %	Annual
2020-12-31	2021-01-13	0.70	0.89 %	Annual
2019-05-28	2019-06-13	1.14	1.90 %	Annual
2018-04-25	2018-05-15	0.94	1.38 %	Annual
2017-05-16	2017-06-08	0.79	1.21 %	Annual
	2016-06-29	0.63	0.97 %	Annual
	2015-06-11	0.55	0.89 %	Annual
	2014-06-17	0.65	1.22 %	Annual
	2013-06-25	0.57	1.01 %	Annual
	2012-06-19	0.57	1.29 %	Annual
	2011-06-09	0.59	1.50 %	Annual
		0.48	1.69 %	Annual
		0.45	1.94 %	Annual
		0.48	1.54 %	Annual

Recent News

EssilorLuxottica to acquire Optegra clinics, another leap forward in its med-tech strategy

2025-05-30 02:00:00

EssilorLuxottica: Disclosure of transactions in own shares

Disclosure of transactions in own shares Paris, France (May 6, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders' Meeting on April 30, 2024, EssilorLuxottica declares that on April 29, 2025, the following share buybacks were carried out: Name of the issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares (€) * Market (MIC Code) ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 29/04/2025 FR0000121667 16,169 249.8663 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 29/04/2025 FR0000121667 6,578 249.9182 CEUX TOTAL 22,747 249.8813 * Rounded to four decimal places Attachment DOWNLOAD THE PRESS RELEASE

2025-05-06 12:00:00

EssilorLuxottica: Disclosure of transactions in own shares

Disclosure of transactions in own shares Paris, France (April 29, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders' Meeting on April 30, 2024, EssilorLuxottica declares that from April 22, 2025, to April 28, 2025, inclusive, the following share buybacks were carried out: Name of the issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares (€) * Market (MIC Code) ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 22/04/2025 FR0000121667 58,184 248.4041 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 22/04/2025 FR0000121667 13,718 248.6304 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 24/04/2025 FR0000121667 18,929 249.5152 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 24/04/2025 FR0000121667 2,474 249.6460 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 24/04/2025 FR0000121667 338 249.5929 TQEX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 24/04/2025 FR0000121667 481 249.6158 AQEU ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 28/04/2025 FR0000121667 30,778 249.9356 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 28/04/2025 FR0000121667 15,983 249.9974 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 28/04/2025 FR0000121667 5,000 249.9855 TQEX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 28/04/2025 FR0000121667 5,000 249.9807 AQEU TOTAL 150,885 249.1768 * Rounded to four decimal places Attachment DOWNLOAD THE PRESS RELEASE

2025-04-29 12:00:00

EssilorLuxottica: Disclosure of transactions in own shares

Disclosure of transactions in own shares Paris, France (April 22, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders' Meeting on April 30, 2024, EssilorLuxottica declares that from April 15, 2025, to April 17, 2025, inclusive, the following share buybacks were carried out: Name of the issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares (€) * Market (MIC Code) ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 15/04/2025 FR0000121667 24,785 249.5423 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 15/04/2025 FR0000121667 18,734 249.7055 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 16/04/2025 FR0000121667 81,951 248.8297 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 16/04/2025 FR0000121667 18,049 248.5505 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 17/04/2025 FR0000121667 60,000 248.0219 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 17/04/2025 FR0000121667 40,000 247.9342 CEUX TOTAL 243,519 248.6028 * Rounded to four decimal places Attachment DOWNLOAD THE PRESS RELEASE

2025-04-22 12:00:00

Clinton Health Access Initiative and OneSight EssilorLuxottica Foundation Launch Strategic Partnership to Expand Vision Care Access Across Africa

KIGALI, Rwanda, April 16, 2025 (GLOBE NEWSWIRE) -- The Clinton Health Access Initiative (CHAI) and the OneSight EssilorLuxottica Foundation have announced a multi-year partnership to advance access to eyeglasses and build sustainable vision care systems across Africa. With a shared focus on health equity, the collaboration aims to address one of the continent's most widespread yet neglected public health challenges: uncorrected poor vision.

2025-04-16 09:12:00

EssilorLuxottica: Disclosure of transactions in own shares

Disclosure of transactions in own shares Paris, France (April 15, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders' Meeting on April 30, 2024, EssilorLuxottica declares that from April 8, 2025, to April 14, 2025, inclusive, the following share buybacks were carried out: Name of the issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares (€) * Market (MIC Code) ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 08/04/2025 FR0000121667 50,000 239.1832 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 08/04/2025 FR0000121667 50,000 239.8201 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 09/04/2025 FR0000121667 60,000 235.5483 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 09/04/2025 FR0000121667 40,000 235.4772 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 10/04/2025 FR0000121667 60,000 246.2568 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 10/04/2025 FR0000121667 40,000 245.5794 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 11/04/2025 FR0000121667 60,000 242.3239 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 11/04/2025 FR0000121667 40,000 242.0555 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 14/04/2025 FR0000121667 61,247 247.1411 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 14/04/2025 FR0000121667 38,753 247.3902 CEUX TOTAL 500,000 242.0923 * Rounded to four decimal places Attachment DOWNLOAD PRESS RELEASE

2025-04-15 12:00:00

EssilorLuxottica: First-Quarter 2025 Revenue Conference Call Invitation

First-Quarter 2025 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure of inviting you to our First-Quarter 2025 Revenue Conference Call on: Wednesday, April 23, 2025, at 6:30 pm CEST Dial-in telephone access: If you wish to dial into the conference call, please pre-register at the following link to receive the personal credentials (Dial-in numbers, Conference ID and User ID): https://grid.trustwavetechnology.com/essilorluxottica/register.html If you encounter any issue in the pre-registration phase you may contact ir@essilorluxottica.com, providing your name and surname and the name of your company. Live webcast: You can watch the presentation at the following link: https://streamstudio.world-television.com/1217-2090-41493/en The press release will be published at 6:00 pm CEST on the same day and the presentation slides will be made available prior to the call.

2025-04-11 12:00:00

EssilorLuxottica: Disclosure of transactions in own shares

Disclosure of transactions in own shares Paris, France (April 8, 2025 - 6:15 pm) – In accordance with the authorization granted by the Annual Shareholders' Meeting on April 30, 2024, EssilorLuxottica declares that from April 3, 2025, to April 7, 2025, inclusive, the following share buybacks were carried out: Name of the issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares (€) * Market (MIC Code) ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 03/04/2025 FR0000121667 165,670 248.5153 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 03/04/2025 FR0000121667 78,114 249.0336 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 03/04/2025 FR0000121667 15,811 248.7312 TQEX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 03/04/2025 FR0000121667 12,696 249.0365 AQEU ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 04/04/2025 FR0000121667 168,339 244.7249 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 04/04/2025 FR0000121667 81,144 244.4314 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 04/04/2025 FR0000121667 16,581 244.4341 TQEX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 04/04/2025 FR0000121667 13,012 244.3856 AQEU ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 07/04/2025 FR0000121667 177,079 234.6622 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 07/04/2025 FR0000121667 86,529 235.1260 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 07/04/2025 FR0000121667 17,754 235.0895 TQEX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 07/04/2025 FR0000121667 13,514 235.1417 AQEU TOTAL 846,243 242.5228 * Rounded to four decimal places Attachment DOWNLOAD THE PRESS RELEASE

2025-04-08 12:15:00

EssilorLuxottica: EssilorLuxottica's employee shareholding plans reach record investment, reflecting strong confidence in the Group's strategy

EssilorLuxottica's employee shareholding plans reach record investment, reflecting strong confidence in the Group's strategy

2025-04-02 13:20:00

EssilorLuxottica: 2024 Universal Registration Document filed

2024 Universal Registration Document filed Paris, France (10 March 2025) – EssilorLuxottica announces the availability of its 2024 Universal Registration Document, in accordance with applicable regulation. The French version of this document, prepared in ESEF format (European Single Electronic Format), was filed with the Autorité des Marchés Financiers (AMF, the French market regulator) on March 10, 2025 under the reference D.25-0081.

2025-03-10 13:00:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions